Consolidated Balance Sheet

Name Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
 Total Current Assets 12,247 10,442 8,555 8,006
Cash and Short Term Investments 3,150 3,037 3,308 3,204
Cash - - -
Cash & Equivalents 3,039 2,864 2,886 3,197
Short Term Investments 111 173 422 7
Total Receivables, Net 3,101 2,683 1,900 1,650
Accounts Receivables - Trade, Net 2,313 1,988 1,297 1,226
Total Inventory 5,289 4,098 2,987 2,696
Prepaid Expenses - - -
Other Current Assets, Total 707 624 360 456
 Total Assets 18,160 14,331 11,899 10,871
Property/Plant/Equipment, Total - Net 2,022 1,671 1,318 1,247
Property/Plant/Equipment, Total - Gross 4,542 3,993 3,456 3,139
Accumulated Depreciation, Total -2,520 -2,322 -2,138 -1,892
Goodwill, Net 1,274 386 379 304
Intangibles, Net 1,614 822 717 597
Long Term Investments 226 445 472 376
Note Receivable - Long Term 442 241 177 123
Other Long Term Assets, Total 335 324 281 218
Other Assets, Total - - -
 Total Current Liabilities 11,232 9,347 7,405 6,533
Accounts Payable 3,604 3,101 2,403 2,660
Payable/Accrued - - -
Accrued Expenses - - -
Notes Payable/Short Term Debt 0 0 0 0
Current Port. of LT Debt/Capital Leases 487 159 - -
Other Current liabilities, Total 7,141 6,087 5,002 3,873
 Total Liabilities 13,506 11,038 8,807 7,759
Total Long Term Debt 867 661 498 497
Long Term Debt 524 521 498 497
Capital Lease Obligations 343 140 - -
Deferred Income Tax 158 147 120 61
Minority Interest 49 52 12 -
Other Liabilities, Total 1,200 831 772 668
 Total Equity 4,654 3,293 3,092 3,112
Redeemable Preferred Stock, Total - - -
Preferred Stock - Non Redeemable, Net - - -
 Common Stock, Total 27 27 28 29
Additional Paid-In Capital 0 - - -
Retained Earnings (Accumulated Deficit) 4,762 3,274 3,039 3,044
Treasury Stock - Common - - -
ESOP Debt Guarantee - - -
Unrealized Gain (Loss) - - -
Other Equity, Total -135 -8 25 39
 Total Liabilities & Shareholders' Equity 18,160 14,331 11,899 10,871
 Total Common Shares Outstanding 1,004.37 976.71 197.28 203.65
 Total Preferred Shares Outstanding - - -

* In Millions of EUR (except for per share

items)
Dec 31, 2016
6,950
3,226
-
3,215
11
1,404
1,057
1,985
-
335
9,931
1,329
3,146
-1,817
309
519
417
104
303
-
5,627
1,666
-
-
0
-
3,961
6,741
496
496
-
34
-
584
3,190
-
-
 30
-
3,114
-
-
-
46
9,931
213.77
-
Cashflow Statement
Name Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
 Net Income/Starting Line 33 -57 771 205
 Cash From Operating Activities -386 -746 743 -21
Depreciation/Depletion - - -
Amortization - - -
Deferred Taxes - - -
Non-Cash Items 193 144 803 809
Cash Receipts - - -
Cash Payments - - -
Cash Taxes Paid 81 63 219 177
Cash Interest Paid 40 - - -
Changes in Working Capital -612 -833 -831 -1,035
 Cash From Investing Activities -538 -344 -267 -256
Capital Expenditures -377 -166 -688 -458
Other Investing Cash Flow Items, Total -161 -178 421 202
 Cash From Financing Activities -564 -309 -234 -186
Financing Cash Flow Items - - -
Total Cash Dividends Paid -228 -209 -208 -208
Issuance (Retirement) of Stock, Net -12 0 - -
Issuance (Retirement) of Debt, Net -324 -309 -25 22
 Foreign Exchange Effects 21 13 -67 -73
 Net Change in Cash -1,467 -1,386 175 -536
Jun 30, 2020
-85
-709
-
-
-
453
-
-
144
-
-1,077
-115
-317
202
-148
-
-
-
60
-50
-1,022
 Consolidated Income Statement
Name Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
 Total Revenue 14,819 12,147 10,134
Revenue 14,819 12,147 10,134
Other Revenue, Total - -
 Cost of Revenue, Total 13,270 10,386 8,501
 Gross Profit 1,549 1,761 1,633
 Total Operating Expenses 14,121 11,143 9,213
Selling/General/Admin. Expenses, Total 368 377 375
Research & Development 62 83 67
Depreciation / Amortization 358 297 223
Interest Expense (Income) - Net Operating - -
Unusual Expense (Income) 63 0 47
Other Operating Expenses, Total - -
 Operating Income 698 1,004 921
 Interest Income (Expense), Net Non-Operating 255 -79 4
 Gain (Loss) on Sale of Assets - -
 Other, Net -19 -16 -15
 Net Income Before Taxes 934 909 910
 Provision for Income Taxes 163 209 227
 Net Income After Taxes 771 700 683
 Minority Interest -6 4 1
 Equity In Affiliates - -
 U.S GAAP Adjustment - -
 Net Income Before Extraordinary Items 765 704 684
 Total Extraordinary Items - -
 Net Income 765 704 684
 Total Adjustments to Net Income - -
 Income Available to Common Excluding Extraordinary Items 765 704 684
 Dilution Adjustment 0 0 -
 Diluted Net Income 765 704 684
 Diluted Weighted Average Shares 982.95 990.84 201.52
 Diluted EPS Excluding Extraordinary Items 0.78 0.71 3.39
 DPS - Common Stock Primary Issue 0.23 0.21 1
 Diluted Normalized EPS 0.83 0.71 3.57
* In Millions of EUR (except for per share items)
Dec 31, 2017 Dec 31, 2016
9,953 10,237
9,953 10,237
- -
7,998 8,099
1,955 2,138
8,723 8,816
444 413
69 63
189 213
- -
23 28
- -
1,230 1,421
-26 -121
- -
-12 -13
1,192 1,287
298 322
894 965
- -
- -
- -
894 965
- -
894 965
- -
894 965
- -
894 965
212.7 219.58
4.2 4.39
1.24 1.31
4.28 4.49